Genética
Estudo de coorte | Uso de contraceptivo oral e risco de câncer ovariano para portadoras de mutações nos genes BRCA1/2.
20 Ago, 2021 | 12:02h
Comentário no Twitter
For #BRCA1 mutation carriers, longer duration of oral contraceptive use (>10 yr) is associated with a greater reduction in #OvarianCancer risk, and the protection is long term. https://t.co/HrrutgaYKX
— Anna Chichura, MD (@AnnaChichuraMD) July 3, 2021
Crianças com atrofia muscular espinal tipo 1 tratadas com risdiplam vs. controles históricos.
5 Ago, 2021 | 11:28hResumo visual: Risdiplam-Treated Infants with Type 1 SMA vs. Historical Controls
Revisão | Esclerose tuberosa para o pneumologista.
5 Ago, 2021 | 11:26hTuberous sclerosis complex for the pulmonologist – European Respiratory Review
Ampla análise genômica identificou 13 novas regiões genômicas associadas a suscetibilidade e gravidade da Covid-19.
13 Jul, 2021 | 11:29hMapping the human genetic architecture of COVID-19 – Nature
Comentários: The quest to find genes that drive severe COVID – Nature E Gene hunters turn up new clues to help explain why Covid-19 hits some people so hard – STAT E Large genomic analysis highlights COVID-19 risk factors – Broad Institute of MIT and Harvard E A new study finds genetic variations in Covid patients that could point to better drug treatments. – The New York Times E How your DNA may affect whether you get COVID-19 or become gravely ill – ScienceNews
OMS divulga novas recomendações sobre a edição do genoma humano para o avanço da saúde pública.
13 Jul, 2021 | 11:20hVer relatórios:
Human genome editing: recommendations
Human genome editing: a framework for governance
Comentários: New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases – Health Policy Watch E WHO should lead on genome-editing policy, advisers say – Nature E WHO Calls for Global Registry of Human Genome Editing – HealthDay E Expert reaction to the WHO’s newly published recommendations and governance framework for human genome editing – Science Media Centre
Comentário no Twitter (fio – clique para saber mais)
Two 🆕 reports provide the first global recommendations to help establish human genome 🧬 editing as a tool for public health, with an emphasis on safety, effectiveness and ethics.
👉 https://t.co/w32QhMXSXi pic.twitter.com/Bto9SF6NzW
— World Health Organization (WHO) (@WHO) July 12, 2021
Revisão | Avanços no diagnóstico e no tratamento da discinesia ciliar primária.
21 Jun, 2021 | 10:46hAdvances in the Diagnosis and Treatment of Primary Ciliary Dyskinesia: A Review – JAMA Otolaryngology – Head & Neck Surgery (gratuito por tempo limitado)
Agora, o CDC chama a variante Delta do coronavírus de “variante de preocupação”.
17 Jun, 2021 | 11:02hCDC now calls coronavirus Delta variant a ‘variant of concern’ – CNN
Diretriz: SARS-CoV-2 Variant Classifications and Definitions – Centers for Disease Control and Prevention
Comentário no Twitter
BREAKING—CDC now officially declares #DeltaVariant a “variant of concern”—because much more transmissible (50% faster than #B117, 2x than original strain), more severe (2.5x hospitalization risk than B117, 4x original) & 1 dose vaccine evasive.🧵 #COVID19https://t.co/jZCgfzFLla pic.twitter.com/SszvXuysze
— Eric Feigl-Ding (@DrEricDing) June 15, 2021
[Preprint] A “variante de preocupação” da Covid-19 B.1.617.2 (Delta) está associada a uma maior transmissibilidade em comparação com a variante B.1.1.7 (Alfa), o que levará a variante Delta a se tornar dominante no Reino Unido.
4 Jun, 2021 | 08:23hRelacionado: Covid: Indian variant ‘now dominant’ in the UK – BBC
Após os sucessos com a COVID-19, pesquisadores se esforçam para desenvolver vacinas de mRNA contra outras doenças infecciosas e câncer.
2 Jun, 2021 | 10:24hO que os cientistas sabem sobre as novas e mais transmissíveis variantes do coronavírus.
26 Mai, 2021 | 10:42hWhat scientists know about new, fast-spreading coronavirus variants – Nature